PATENT CLAIM ANALYSIS

Application Number: 15861853
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "005900"]

Abstract:
The present system is directed in one embodiment to a method of administration of a therapeutic composition for treatment, prevention and/or mitigation of the frequency and/or severity of impaired awareness of hypoglycemia (IAH). The method includes administering one or more therapeutic agent(s) or composition(s) comprising insulin to the upper third of a patient's nasal cavity, thereby delivering the therapeutic composition directly to the patient's central nervous system for treatment, prevention and/or mitigation of the frequency and/or severity of IAH. In still another embodiment, the therapeutic composition comprises a non-zinc containing form of insulin.

Claim (Index 4):
The method of  claim 1 , further comprising administering a vasoconstrictor to the patient.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 86.0
- Lexical Diversity: 1.92982
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14040915', '15340160', '14679667', '14202932', '12134385']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7395983423547519
- 35 USC 102 Novelty (BERT): 0.5288225090341414
- Combined Prediction Score: 0.7185207590226909
- Mean Citation Score: 303.49486
- Max Citation Score: 336.12085
- Similarity Product: 268.3278082449019

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test